Human ARF protein interacts with Topoisomerase I and stimulates its activity

被引:78
|
作者
Karayan, L
Riou, JF
Séité, P
Migeon, J
Cantereau, A
Larsen, CJ [1 ]
机构
[1] CHU Poitiers, Lab Biochim Prot, Poitiers, France
[2] Oncol Mol Lab, CNRS, FRE 2224, Poitiers, France
[3] IFR Commun Intercellulaire, CNRS, UMR 6558, Serv Cytofluorometrie, F-86021 Poitiers, France
[4] Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, Aventis Pharma, F-94403 Vitry Sur Seine, France
关键词
p14(ARF); Topoisomerase I; protein interactions;
D O I
10.1038/sj.onc.1204170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ARF gene (p19(ARF) in mouse and p14(ARF) in man) has become a central actor of the cell cycle regulation process as it participates to the ARF-MDM2-p53 pathway and the Rh-E2F-1 pathway. By use of immunoprecipitation and Western blotting (IP/WB), we now show that ARF physically associates with Topoisomerase I(Topo I), ARF-Topo I immune complexes were detected in SF9 insect cells infected with recombinant baculoviruses encoding the two genes as well as in 293 cells that express endogeneously these proteins. Preparations of a GST-ARF recombinant protein stimulated the DNA relaxation activity of Topo I but, in contrast, had no effect an the decatenation activity of Topo TT, The Topo I stimulation was also detected in cell extracts of SF9 cells expressing both proteins, A confocal microscopy study indicated that part of ARF and Topo I colocalized in the granular component structure of the nucleolus. As a whole, our data indicate that Topo I is a new partner of ARF and suggest that ARF is involved in cell reactions that require Topo I.
引用
收藏
页码:836 / 848
页数:13
相关论文
共 50 条
  • [31] Stimulation of human DNA topoisomerase II activity by its direct association with the β subunit of protein kinase CKII
    Park, GH
    Lee, YT
    Bae, YS
    MOLECULES AND CELLS, 2001, 11 (01) : 82 - 88
  • [32] The human tumor suppressor ARF interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein
    Vivo, M
    Calogero, RA
    Sansone, F
    Calabrò, V
    Parisi, T
    Borrelli, L
    Saviozzi, S
    La Mantia, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 14161 - 14169
  • [33] The RecX protein interacts with the RecA protein and modulates its activity in Herbaspirillum seropedicae
    Galvao, C. W.
    Souza, E. M.
    Etto, R. M.
    Pedrosa, F. O.
    Chubatsu, L. S.
    Yates, M. G.
    Schumacher, J.
    Buck, M.
    Steffens, M. B. R.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (12) : 1127 - 1134
  • [34] INHIBITION OF DNA TOPOISOMERASE-I ACTIVITY BY DIETHYLSTILBESTROL AND ITS ANALOGS
    ODA, T
    SATO, Y
    KODAMA, M
    KANEKO, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1993, 16 (07) : 708 - 710
  • [35] Activation of human topoisomerase I by protein kinase CK2
    Kowalska-Loth, B
    Girstun, A
    Derlacz, R
    Staron, K
    MOLECULAR BIOLOGY REPORTS, 2003, 30 (02) : 107 - 111
  • [36] Activation of human topoisomerase I by protein kinase CK2
    Barbara Kowalska-Loth
    Agnieszka Girstun
    Rafal Derlacz
    Krzysztof Staroń
    Molecular Biology Reports, 2003, 30 : 107 - 111
  • [37] Protein concerted motions in the DNA-human topoisomerase I complex
    Chillemi, G
    Fiorani, P
    Benedetti, P
    Desideri, A
    NUCLEIC ACIDS RESEARCH, 2003, 31 (05) : 1525 - 1535
  • [38] Erratum: Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
    Olivier Ayrault
    Lucie Karayan
    Jean-François Riou
    Christian-Jacques Larsen
    Paule Séité
    Oncogene, 2006, 25 : 2827 - 2827
  • [39] PTEN interacts with metal-responsive transcription factor 1 and stimulates its transcriptional activity
    Lin, Meng-Chieh
    Liu, Ya-Chuan
    Tam, Ming F.
    Lu, Yu-Ju
    Hsieh, Ya-Ting
    Lin, Lih-Yuan
    BIOCHEMICAL JOURNAL, 2012, 441 : 367 - 377
  • [40] Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies
    Bronstein, IB
    Vorobyev, S
    Timofeev, A
    Jolles, CJ
    Alder, SL
    Holden, JA
    ONCOLOGY RESEARCH, 1996, 8 (01) : 17 - 25